Manufacturers Life Insurance Company, The Galectin Therapeutics Inc Transaction History

Manufacturers Life Insurance Company, The

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$2.24 - $2.87 $60,074 - $76,970	-26,819 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$2.53 - $3.64 $12,885 - $18,538	5,093 Added 23.44%	26,819 $72,000
Q2 2020 Aug 10, 2020	SELL	$1.66 - $3.15 $14,196 - $26,938	-8,552 Reduced 28.24%	21,726 $66,000
Q1 2020 May 15, 2020	BUY	$1.51 - $3.0 $3,808 - $7,566	2,522 Added 9.09%	30,278 $59,000
Q4 2019 Feb 14, 2020	BUY	$2.79 - $4.32 $4,165 - $6,449	1,493 Added 5.68%	27,756 $79,000
Q3 2019 Nov 12, 2019	BUY	$3.0 - $4.05 $2,304 - $3,110	768 Added 3.01%	26,263 $95,000
Q2 2019 Aug 14, 2019	BUY	$3.61 - $5.0 $92,036 - $127,475	25,495 New	25,495 $106,000
Q3 2018 Nov 14, 2018	SELL	$3.68 - $6.93 $706 - $1,330	-192 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.78 - $5.97 $725 - $1,146	192 New	192 $1,000

9.69M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $73.7M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.